2004
DOI: 10.1016/j.neucli.2004.01.004
|View full text |Cite
|
Sign up to set email alerts
|

Atypical electrophysiologic findings in chronic inflammatory demyelinating polyneuropathy (CIDP) – diagnosis confirmed by nerve biopsy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
25
0

Year Published

2007
2007
2017
2017

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 27 publications
(25 citation statements)
references
References 28 publications
0
25
0
Order By: Relevance
“…When the presence of pain was not reported and when analgaesics were not used we assumed that pain was not present. We did not analyse EMG findings because these examinations were not always performed in a standardised fashion in this two-centre study 12 24 25…”
Section: Methodsmentioning
confidence: 99%
“…When the presence of pain was not reported and when analgaesics were not used we assumed that pain was not present. We did not analyse EMG findings because these examinations were not always performed in a standardised fashion in this two-centre study 12 24 25…”
Section: Methodsmentioning
confidence: 99%
“…This finding might reflect the fact that the main pathology during the early phase of CIDP is segmental demyelination, unless secondary axonal degeneration occurs (Boukhris et al, 2004;Harbo et al, 2008;Kuwabara et al, 2006;Said, 2006). In the early stages of CIDP, muscle structures tend to be preserved due to the limited denervation.…”
Section: Comparison Of Mus Findings Between the Cidp And Nc Groupsmentioning
confidence: 99%
“…Although the main pathology in CIDP is segmental demyelination, several studies demonstrated coexistence of axonal degeneration following segmental demyelination termed secondary axonal degeneration (Bouchard et al, 1999;Boukhris et al, 2004;Said, 2006;Sghirlanzoni et al, 2000). Differentiating segmental demyelination from secondary axonal degeneration in patients with CIDP is essential as the latter suggests unresponsiveness to medication and unfavorable prognosis (Bouchard et al, 1999;Iijima et al, 2005;Said, 2006;Sghirlanzoni et al, 2000).…”
Section: Introductionmentioning
confidence: 99%
“…Numerous clinical forms have been described [4][5][6][7], among which the purely sensory forms [7,8] with paresthesiae, ataxia and occasional pain. However, pain is generally described as a secondary sign of the disease.…”
Section: Introductionmentioning
confidence: 99%